We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Enterprise Therapeutics Receives Funding from Cystic Fibrosis Trust

News   Apr 05, 2017 | Original story from Enterprise Therapeutics

 
Enterprise Therapeutics Receives Funding from Cystic Fibrosis Trust
 
 
 

RELATED ARTICLES

Aging in Older Mice Delayed by Giving Enzyme From Younger Mice

News

New research has identified a novel approach to staving off the detrimental effects of aging in mice.

READ MORE

Human Blood-Brain Barrier Chip Aids Development of Brain-targeting Drugs

News

A microfluidic organ chip model of the human blood-brain barrier, that recapitulates in vivo barrier functions, offers a new preclinical tool for development of brain-targeting therapeutics.

READ MORE

Vaccine Drives Antibodies to Target Tau Tangles in Mice

News

A vaccine pioneered by virus-like particles induced a robust and long-lived antibody response to tau protein in mice, reducing soluble and insoluble species of Tau in the hippocampus and cortex.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE